| 000 | 01390 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513192916.0 | ||
| 264 | 0 | _c19991105 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/s0049-3848(99)00077-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHellstern, P | |
| 245 | 0 | 0 |
_aProthrombin complex concentrates: indications, contraindications, and risks: a task force summary. _h[electronic resource] |
| 260 |
_bThrombosis research _cAug 1999 |
||
| 300 |
_aS3-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBlood Coagulation Factors _xstandards |
| 650 | 0 | 4 |
_aCoagulation Protein Disorders _xdrug therapy |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 |
_aDisseminated Intravascular Coagulation _xdrug therapy |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aProthrombin _xstandards |
| 650 | 0 | 4 | _aReference Standards |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 |
_aVitamin K Deficiency _xdrug therapy |
| 700 | 1 | _aHalbmayer, W M | |
| 700 | 1 | _aKöhler, M | |
| 700 | 1 | _aSeitz, R | |
| 700 | 1 | _aMüller-Berghaus, G | |
| 773 | 0 |
_tThrombosis research _gvol. 95 _gno. 4 Suppl 1 _gp. S3-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0049-3848(99)00077-8 _zAvailable from publisher's website |
| 999 |
_c10457073 _d10457073 |
||